Inhalator
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a top perspective view of an inhalator showing our new design, in closed position;
FIG. 2 is a top perspective view thereof, in open position;
FIG. 3 is a top plan view thereof;
FIG. 4 is a right side elevational view, the left side elevational view being a mirror image thereof;
FIG. 5 is a front elevational view thereof;
FIG. 6 is a bottom plan view thereof; and
FIG. 7 is a rear elevational view thereof.
Referenced Cited
Patent History
Patent number: D299066
Type: Grant
Filed: Mar 13, 1986
Date of Patent: Dec 20, 1988
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Stella M. Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/844,284
Type: Grant
Filed: Mar 13, 1986
Date of Patent: Dec 20, 1988
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Stella M. Reid
Law Firm: McAulay, Fields, Fisher, Goldstein & Nissen
Application Number: 6/844,284
Classifications
Current U.S. Class:
D24/62